Prostate cancer remains the most common cancer in men with an estimated 164,690 new cases in 2018. Despite how common prostate cancer is, there are limitations in our ability to detect it based on traditional screening and biopsy methods.
Multi-parametric MRI of the prostate has emerged as a new tool to help urologists detect prostate cancer. Since 2016, at the University of Florida (UF), we have been using the UroNav Fusion Biopsy System to merge a patient’s pre-biopsy MRI images of the prostate with the ultrasound-guided biopsy images in real time to allow for a targeted and more precise prostate biopsy. This system has improved our prostate cancer detection rates in men with a prior negative biopsy and persistently suspicious PSA test as well as helped us better select patients for active surveillance of their prostate cancer.
All patients who undergo a UroNav fusion prostate biopsy at UF have their history and MRI reviewed by our dedicated multidisciplinary team of radiologists, urologists, radiation oncologists and pathologists both before and after the fusion biopsy. This allows us to both optimally plan our fusion biopsies and formulate treatment recommendations if prostate cancer is detected.
To schedule an appointment please call, 352.265.8240.
Joseph R Grajo, MD
Assistant Professor, Abdominal Imaging, Vice Chair for Research, Associate Program Director, Diagnostic Radiology Residency Program, Program Director, Abdominal Imaging Fellowship, Director of Body MRI
Click here for Video Biography